CAS: 1360457-46-0; 2-((3R,6S)-2-Hydroxy-3-(2-(Thiophen-2-yl)Acetamido)-1,2-Oxaborinan-6-yl)Acetic Acid

该化合物是一种复杂的有机化合物,其独特的结构特征具有这一化合物的特点,包括含有黄黄氧环,该化合物展示了气质,在3和6个位置上具有特定的立体化学,能够影响其生物活动和相互作用; 一种氢化合体和乙酸合金的存在有助于其作为极分子的潜力,增强水生环境中的溶性; 乙基基酸组引入了芳香特性,这可能影响到化合物的电子特性和再活动; 此外,这种氨联结表明氢联,影响其稳定性和与生物目标的相互作用;

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

(3S,6R)-Tert-Butyl 3-(Tert-Butyldimethylsilyloxy)-6-(2-Thiophen-2-Yl-Acetylamino)-6-[(2S,6R)-2,9,9-Trimethyl-3,5-Dioxa-4-Boratricyclo[6.1.1.02,6]Decan-4-Yl]Hexanoate 1681053-97-3

合成工艺路线路线简述

    📜2-噻吩乙酸置于盐酸,Nickel(II) Chloride Hexahydrate,三乙氧基硅烷,四丁基碘化铵,(S)-3-Amino-2-Benzyl-1,4-Diphenylbutan-2-Ol,N,N'-羰基二咪唑体系中,用 四氢呋喃,1,4-二氧六环,二氯甲烷,N,N-二甲基乙酰胺,水 用作溶剂,化学反应 26.0H,反应生成法硼巴坦
    参考文献:一种镍催化的不对称氢酰胺化制备手性α-氨基硼酸/硼酸酯的方法
    标题:一种镍催化的不对称氢酰胺化制备手性α-氨基硼酸/硼酸酯的方法
    摘要:本发明公开了一种镍催化的不对称氢酰胺化制备手性α‑氨基硼酸/硼酸酯的方法.在金属镍盐,手性配体,氢源,添加剂等作用下,使烯烃和酰胺化试剂溶于有机溶剂中进行反应,得到区域选择性和对映选择性优秀的手性α‑氨基硼酸/硼酸酯.本方法原料易得,催化剂简单,操作简便,利用本方法可以合成一系列含有手性α‑氨基硼酸/硼酸酯的药物(生物活性)分子,如vaborbactam.

    海关参考信息

    专利信息


    专利号:US-10669292-B2
    优先权日:2014-05-05
    标 题 :Synthesis of boronate salts and uses thereof
    发明人:HECKER SCOTT; BOYER SERGE
    权利人:REMPEX PHARMACEUTICALS INC
    摘要:Disclosed herein are boronate intermediates in the synthesis of antimicrobial compounds and the use and preparation thereof. Some embodiments relate to crystalline boronate salt derivatives and their use in the synthesis of therapeutic compounds.

    专利号:US-9249175-B2
    优先权日:2008-09-05
    标 题 :RNA monomers containing O-acetal levulinyl ester groups and their use in RNA microarrays
    发明人:DAMHA MASAD; LACKEY JEREMY; MITRA DEBBIE; WICKENS MARVIN; CERRINA FRANCO; SOMOZA MARK
    权利人:DAMHA MASAD; LACKEY JEREMY; MITRA DEBBIE; WICKENS MARVIN; CERRINA FRANCO; AKHTAR SAIMA A; SOMOZA MARK; ROYAL INST FOR THE ADVANCEMENT OF LEARNING MCGILL UNIVERSITY; WISCONSIN ALUMNI RES FOUND
    摘要:The present invention is directed to RNA monomers comprising O-acetal levulinyl protecting groups at the 2′ and/or the 5′-hydroxy functionalities of the ribose moiety. Said monomers may be incorporated into oligoribonucleotides or RNA polynucleotides. Furthermore, the invention is directed to methods for the synthesis of said RNA monomers, oligoribonucleotides and RNA polynucleotides, as well as methods for their deprotection and methods for the use of said compounds and compositions comprising said compounds. In particular, such compounds and compositions comprising them are used in methods for light-directed synthesis of RNA microarrays.

    专利号:US-7820858-B2
    优先权日:2006-03-25
    标 题 :Concise β2-amino acid synthesis via organocatalytic aminomethylation
    发明人:CHI YONGGUI; GELLMAN SAMUEL H; POMERANTZ WILLIAM C; HORNE WILLIAM S; GUO LI; ENGLISH EMILY P
    权利人:WISCONSIN ALUMNI RES FOUND
    摘要:The present invention provides a method for the synthesis of β 2 -amino acids. The method also provides methods yielding α-substituted β-amino aldehydes and β-substituted γ-amino alcohols. The present method according to this invention allows for increased yield and easier purification using minimal chromatography or crystallization. The methods described herein are based on an aldehyde aminomethylation which involves a Mannich reaction between an aldehyde and a formaldehyde-derived N,O-acetal (iminium precursor) and a catalyst, such as, for example, L-proline or a pyrrolidine. The invention allows for large scale, commercial preparation of β 2 -amino acids.

    专利号:US-9969686-B2
    优先权日:2014-08-05
    标 题 :Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them
    发明人:TANG WEIPING; LI XIAOXUN; SHU DONGXU; WINSTON-MCPHERSON GABRIELLE N
    权利人:WISCONSIN ALUMNI RES FOUND
    摘要:Described is a method to make diindolylmethanes and indolyl/pyrrolylmethanes, The method includes the steps of contacting an ether comprising an arylpropargyl moiety and an amine-protected, substituted or unsubstituted aniline moiety with a substituted or unsubstituted indol or a substituted or unsubstituted pyrrole, in the presence of a metal-containing catalyst, for a time and at a temperature to cause an annulation/arylation cascade reaction that yields a diindolylmethane or a indolyl/pyrrolylmethane. The resulting compounds are effective to modulate activity of arylhydrocarbon receptors, to inhibit activity of PCSK9, and to stimulate secretion of glucagon-like peptide 1 in mammals.

    专利号:US-2023212216-A1
    优先权日:2019-12-20
    标 题:Synthesis of lactone derivatives and their use in the modification of proteins
    发明人:MORRIS ALEXANDER REDFERN; SUTOV GRIGORIJ; BRUNE KARL DIETRICH
    权利人:GENIE BIOTECH UK LTD
    摘要:Site-specific modifications of proteins are desirable in biotechnological applications such as biopharmaceuticals, immunotherapy, vaccines, and are useful in chemical biology. Gluconoylation is a non-enzymatic, covalent, post-translational modification commonly observed on N-terminal His-Tags bearing proteins. We synthesized glucono-1,5-lactone derivatives, including azido variants for selective acylation. High yield acylation is achieved by simply mixing derivatives with target protein amidst diverse conditions of temperatures, aqueous buffers, excipients, or complex cell lysate.

    专利号:US-8106031-B2
    优先权日:2006-05-02
    标题:Hydrolytically-resistant boron-containing therapeutics and methods of use
    发明人:LEE VING; PLATTNER JACOB J; BENKOVIC STEPHEN J; BAKER STEPHEN J; MAPLES KIRK R; BELLINGER-KAWAHARA CAROLYN; AKAMA TSUTOMU; ZHANG YONG-KANG; SINGH RAJESHWAR; SAURO VITTORIO A
    权利人:LEE VING; PLATTNER JACOB J; BENKOVIC STEPHEN J; BAKER STEPHEN J; MAPLES KIRK R; BELLINGER-KAWAHARA CAROLYN; AKAMA TSUTOMU; ZHANG YONG-KANG; SINGH RAJESHWAR; SAURO VITTORIO A; ANACOR PHARMACEUTICALS INC
    摘要:Compositions and methods of use of boron derivatives, including benzoxaboroles, benzazaboroles and benzthiaboroles, as therapeutic agents for treatment of diseases caused by fungi, yeast, bacteria or viruses are disclosed, as well as methods for synthesis of said agents and compositions thereof.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Gibson B. A Brief Review of a New Antibiotic: Meropenem-vaborbactam. Sr Care Pharm. 2019 Mar 1;34(3):187-191. Review. doi: 10.1080/14787210.2018.1542300. Epub 2018 Nov 5. Review. doi: 10.2147/IDR.S150447. eCollection 2018. Review.
    4: Wu G, Cheon E. Meropenem-vaborbactam for the treatment of complicated urinary tract infections including acute pyelonephritis. Expert Opin Pharmacother. 2018 Sep;19(13):1495-1502. doi: 10.1080/14656566.2018.1512586. Epub 2018 Aug 30. Review. doi: 10.1007/s40265-018-0966-7. Review. Erratum in: Drugs. 2018 Sep;78(13):1383.
    6: Burgos RM, Biagi MJ, Rodvold KA, Danziger LH. Pharmacokinetic evaluation of meropenem and vaborbactam for the treatment of urinary tract infection. Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):1007-1021. doi: 10.1080/17425255.2018.1511702. Epub 2018 Sep 19. Review. doi: 10.1007/s10096-018-3260-4. Epub 2018 Apr 19. Review. doi: 10.1177/1060028018763288. Epub 2018 Mar 7. Review. doi: 10.1002/phar.2092. Epub 2018 Mar 28. Review. doi: 10.1358/dot.2017.53.10.2721815. Review. doi: 10.1007/s40265-017-0851-9. Review. Erratum in: Drugs. 2018 May 10;:.

    合成参考文献


    参考文献:10.1007/s10928-017-9506-4
    摘要:Bush K, Page MGP. What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles. Journal of Pharmacokinetics and Pharmacodynamics. 2017 Feb 04;44(2):113–32. doi: 10.1007/s10928-017-9506-4.
    参考文献:10.1177/2168479017750129
    摘要:Baldrick P. Juvenile Animal Testing: Assessing Need and Use in the Drug Product Label. Ther Innov Regul Sci. 2018 Sep;52(5):641–8. doi: 10.1177/2168479017750129.
    参考文献:10.1007/s11908-018-0617-x
    摘要:Porreca AM, Sullivan KV, Gallagher JC. The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms. Curr Infect Dis Rep. 2018 May 05;20(6):13. doi: 10.1007/s11908-018-0617-x.
    参考文献:10.1007/s00109-019-01803-y
    摘要:Wang H, Jayaraman A, Menon R, Gejji V, Karthikeyan R, Fernando S. A non-beta-lactam antibiotic inhibitor for enterohemorrhagic Escherichia coli O104:H4. Journal of Molecular Medicine. 2019 Jun 28;97(9):1285–97. doi: 10.1007/s00109-019-01803-y.
    参考文献:10.1128/aac.00398-20
    摘要:Pemberton OA, Tsivkovski R, Totrov M, Lomovskaya O, Chen Y. Structural Basis and Binding Kinetics of Vaborbactam in Class A β-Lactamase Inhibition. Antimicrob Agents Chemother. 2020 Sep 21;64(10).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知